The U.S. discovers many new medicines, but often cannot make them at large scale at home. This cause supports creating a national Biopharmaceutical Center of Excellence to improve drug manufacturing, train workers, and reduce shortages. Winning means Congress advances and funds the Biomanufacturing Excellence Act so a pilot center can launch.
No open cycle
This cause does not have an open cycle right now. Your grant status is still available in the dashboard.
Create biopharmaceutical centers of excellence
19
DAYS LEFT23,088
Votes
$35,948
Raised
$15,777
Sponsors
A new plan to make more medicines in America
Why this matters now
When more of the medicine supply chain sits overseas, the U.S. has less control during emergencies and disruptions. COVID-19 exposed how hard it can be to ramp up production fast, and shortages of critical medicines can follow.
A Center of Excellence is meant to rebuild practical “how to manufacture” capacity, not just research. It could help the U.S. make advanced products like biologics, vaccines, and gene therapies more reliably, while training people to run modern manufacturing.
What's blocking progress
The biggest hurdle is sustained funding and agreement on which agencies lead and how the public-private partnership is run. Location politics and slow coordination across agencies could also delay a launch.
Strategies
Choose which strategies should receive funding this cycle.
0 grant votes available this cycle
Ballot edits are currently read only.
Community discussion
Start a discussion
Sign in to postDiscussion posting still runs on the legacy demo auth path and stays isolated from the Phase 1 Supabase backend.
- No threads yet. Be the first to post once the legacy discussion path is migrated.
Impact stories
Impact updates will appear here after the first cycle closes.